Rocket Lab acquires Iridium for $8B in a historic space industry deal — combining launch, satellite manufacturing, spectrum, and a 66-satellite LEO network.
FDA approved Tregzi, the first regulatory T cell therapy for allogeneic stem cell transplant in blood cancers. The Phase 3 Precision-T trial cut chronic GVHD by 74% — 78% cGVHD-free survival at 12 months vs 38% with conventional transplant.
At $500 million, Flourish is the largest bet ever placed on the idea that copying the brain's wiring — not scaling GPUs — is the only path out of AI's energy crisis.
Nauticus Robotics secured a $250M equity line of credit to fund deep-sea rare earth exploration and a defense sector pivot. Analysis of the autonomous subsea robotics company at the intersection of critical minerals, defense contracting, and energy transition.
SPRIND Orbital Bioworks challenge closes July 3 with €1.65M prize pool. WFIRM sends 3D bioprinted liver to ISS. Varda, Starlab, and Axiom build orbital bioprocessing infrastructure.
Quantum inertial sensors have matched or exceeded conventional navigation accuracy in real-world field trials — on aircraft, naval vessels, and in orbit. Q-CTRL, Vector Atomic, and DeteQt are racing to replace satellite-dependent positioning for defence and space.
Insitro has raised 100M to build TherML, a modality-agnostic AI engine for drug discovery. Early pharma validation from Lilly and BMS.
Deep tech now accounts for 36% of global venture capital, up from 12% in 2016 — a structural reallocation driven by AI infrastructure, defense tech, and bioconvergence.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
